Shandong Tianming Pharmaceutical Group founded in 2010, the group is headquartered in Jinan, known as the City of Springs. It is mainly engaged in the R&D, production and sales of chemical active pharmaceutical ingredients (APIs) and intermediates, as well as CMO/CDMO services for pharmaceutical intermediates and APIs.

The group has two R&D centers: Shandong Tianming Pharmaceutical (Jinan) R&D Center and Nanjing Tianming Pharmaceutical (Nanjing) R&D Center; and three production bases: Shandong Sihuan Pharmaceutical (Pingyuan, Shandong), Jining Tianming Pharmaceutical (Jining, Shandong) and Guangxi Tianming Pharmaceutical (Hechi, Guangxi).

Boasting a workforce of over 400 employees, the group achieves an annual output value of more than 300 million CNY.

At present, it offers a range of chemical APIs and intermediates covering multiple therapeutic areas including diabetes, cardiovascular diseases, anti-infection, anti-virus and anti-tumor, along with products of food ingredients and cosmetic ingredients.

1.Cardiovascular Products: Sacubitril Valsartan Sodium and its full-chain intermediates of Sacubitril.

2.Anti-Diabetic/Weight Loss Products: Alogliptin and its intermediates, Linagliptin and its full-chain intermediates, Empagliflozin and its full-chain intermediates, Dapagliflozin and its intermediates, Finerenone and its intermediates, Ogletruline and its intermediates.

3.Anti-Infective Products: Avibactam Sodium and its intermediates, Tenofovir Alafenamide Fumarate and its intermediates.

4.Insomnia Treatment Drugs: Lemborexant and its intermediates, Voronorexant and its intermediates.

5.Other Major Pharmaceutical Intermediates: Nicotine series intermediates, N,N-Dimethylaminoethyl Chloride Hydrochloride, 4-Methylthiazole-5-carboxaldehyde.

6.Food Raw Materials and Cosmetic Raw Materials: PQQ (food raw material), Idebenone (cosmetic raw material).